nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilvadipine—CYP3A4—bone cancer	0.874	1	CbGaD
Nilvadipine—CACNA1S—pes—bone cancer	0.0129	0.643	CbGeAlD
Nilvadipine—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00276	0.0289	CbGpPWpGaD
Nilvadipine—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00218	0.0228	CbGpPWpGaD
Nilvadipine—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00188	0.0197	CbGpPWpGaD
Nilvadipine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.0018	0.0189	CbGpPWpGaD
Nilvadipine—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00168	0.0176	CbGpPWpGaD
Nilvadipine—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00159	0.0167	CbGpPWpGaD
Nilvadipine—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00153	0.0161	CbGpPWpGaD
Nilvadipine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00146	0.0153	CbGpPWpGaD
Nilvadipine—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00146	0.0153	CbGpPWpGaD
Nilvadipine—Lercanidipine—CYP3A4—bone cancer	0.00141	0.139	CrCbGaD
Nilvadipine—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.00133	0.0139	CbGpPWpGaD
Nilvadipine—CACNA1S—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.00132	0.0138	CbGpPWpGaD
Nilvadipine—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00131	0.0137	CbGpPWpGaD
Nilvadipine—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00128	0.0134	CbGpPWpGaD
Nilvadipine—Isradipine—CYP3A4—bone cancer	0.00128	0.126	CrCbGaD
Nilvadipine—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00126	0.0132	CbGpPWpGaD
Nilvadipine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00118	0.0123	CbGpPWpGaD
Nilvadipine—CACNA2D3—tendon—bone cancer	0.00115	0.0571	CbGeAlD
Nilvadipine—Clevidipine—CYP3A4—bone cancer	0.00112	0.111	CrCbGaD
Nilvadipine—CACNA2D3—bone marrow—bone cancer	0.00111	0.0553	CbGeAlD
Nilvadipine—CACNA2D3—spinal cord—bone cancer	0.00111	0.0551	CbGeAlD
Nilvadipine—Nisoldipine—CYP3A4—bone cancer	0.00108	0.106	CrCbGaD
Nilvadipine—CACNB2—Regulation of insulin secretion—GNA11—bone cancer	0.00107	0.0112	CbGpPWpGaD
Nilvadipine—CACNA1D—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.00107	0.0112	CbGpPWpGaD
Nilvadipine—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.00105	0.011	CbGpPWpGaD
Nilvadipine—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.00105	0.011	CbGpPWpGaD
Nilvadipine—Nimodipine—CYP3A4—bone cancer	0.00104	0.103	CrCbGaD
Nilvadipine—CACNA1D—Regulation of insulin secretion—GNA11—bone cancer	0.00101	0.0106	CbGpPWpGaD
Nilvadipine—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.00101	0.0106	CbGpPWpGaD
Nilvadipine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00101	0.0106	CbGpPWpGaD
Nilvadipine—Nitrendipine—CYP3A4—bone cancer	0.00101	0.0993	CrCbGaD
Nilvadipine—CACNA1S—tendon—bone cancer	0.000991	0.0492	CbGeAlD
Nilvadipine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00095	0.00996	CbGpPWpGaD
Nilvadipine—CACNA1C—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000938	0.00983	CbGpPWpGaD
Nilvadipine—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000937	0.00982	CbGpPWpGaD
Nilvadipine—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000913	0.00957	CbGpPWpGaD
Nilvadipine—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000908	0.00952	CbGpPWpGaD
Nilvadipine—CACNA1C—Regulation of insulin secretion—GNA11—bone cancer	0.000889	0.00931	CbGpPWpGaD
Nilvadipine—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000874	0.00915	CbGpPWpGaD
Nilvadipine—Amlodipine—CYP3A4—bone cancer	0.000869	0.0855	CrCbGaD
Nilvadipine—CACNB2—Integration of energy metabolism—GNA11—bone cancer	0.00084	0.0088	CbGpPWpGaD
Nilvadipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000828	0.00867	CbGpPWpGaD
Nilvadipine—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000811	0.0085	CbGpPWpGaD
Nilvadipine—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.00081	0.00849	CbGpPWpGaD
Nilvadipine—Felodipine—CYP3A4—bone cancer	0.000803	0.0791	CrCbGaD
Nilvadipine—CACNA1D—Integration of energy metabolism—GNA11—bone cancer	0.000795	0.00833	CbGpPWpGaD
Nilvadipine—CACNA2D3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000787	0.00824	CbGpPWpGaD
Nilvadipine—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.00078	0.00817	CbGpPWpGaD
Nilvadipine—Nifedipine—CYP3A4—bone cancer	0.000777	0.0765	CrCbGaD
Nilvadipine—Nicardipine—CYP3A4—bone cancer	0.000765	0.0753	CrCbGaD
Nilvadipine—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000755	0.00791	CbGpPWpGaD
Nilvadipine—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000739	0.00775	CbGpPWpGaD
Nilvadipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000735	0.0077	CbGpPWpGaD
Nilvadipine—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000723	0.00758	CbGpPWpGaD
Nilvadipine—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000711	0.00745	CbGpPWpGaD
Nilvadipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000707	0.00741	CbGpPWpGaD
Nilvadipine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000704	0.00738	CbGpPWpGaD
Nilvadipine—CACNA1C—connective tissue—bone cancer	0.000699	0.0347	CbGeAlD
Nilvadipine—CACNA1C—Integration of energy metabolism—GNA11—bone cancer	0.000699	0.00732	CbGpPWpGaD
Nilvadipine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000687	0.0072	CbGpPWpGaD
Nilvadipine—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000687	0.0072	CbGpPWpGaD
Nilvadipine—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000659	0.00691	CbGpPWpGaD
Nilvadipine—CACNA2D3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000659	0.00691	CbGpPWpGaD
Nilvadipine—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000658	0.0069	CbGpPWpGaD
Nilvadipine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000635	0.00665	CbGpPWpGaD
Nilvadipine—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000632	0.00662	CbGpPWpGaD
Nilvadipine—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000608	0.00637	CbGpPWpGaD
Nilvadipine—CACNA2D3—Neuronal System—BRAF—bone cancer	0.000603	0.00632	CbGpPWpGaD
Nilvadipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000597	0.00625	CbGpPWpGaD
Nilvadipine—CACNB2—tendon—bone cancer	0.000595	0.0296	CbGeAlD
Nilvadipine—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000563	0.0059	CbGpPWpGaD
Nilvadipine—CACNA2D1—tendon—bone cancer	0.000559	0.0278	CbGeAlD
Nilvadipine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000557	0.00583	CbGpPWpGaD
Nilvadipine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000552	0.00579	CbGpPWpGaD
Nilvadipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000546	0.00572	CbGpPWpGaD
Nilvadipine—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000545	0.00571	CbGpPWpGaD
Nilvadipine—CACNA2D1—bone marrow—bone cancer	0.000542	0.0269	CbGeAlD
Nilvadipine—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.00054	0.00566	CbGpPWpGaD
Nilvadipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000524	0.00549	CbGpPWpGaD
Nilvadipine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000508	0.00532	CbGpPWpGaD
Nilvadipine—CACNA2D3—Neuronal System—MDM2—bone cancer	0.000505	0.00529	CbGpPWpGaD
Nilvadipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000484	0.00507	CbGpPWpGaD
Nilvadipine—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000448	0.00469	CbGpPWpGaD
Nilvadipine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000436	0.00457	CbGpPWpGaD
Nilvadipine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000435	0.00456	CbGpPWpGaD
Nilvadipine—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000431	0.00451	CbGpPWpGaD
Nilvadipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000413	0.00433	CbGpPWpGaD
Nilvadipine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000377	0.00395	CbGpPWpGaD
Nilvadipine—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000372	0.0039	CbGpPWpGaD
Nilvadipine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000356	0.00373	CbGpPWpGaD
Nilvadipine—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000354	0.00371	CbGpPWpGaD
Nilvadipine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000337	0.00353	CbGpPWpGaD
Nilvadipine—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000332	0.00348	CbGpPWpGaD
Nilvadipine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000324	0.0034	CbGpPWpGaD
Nilvadipine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000307	0.00322	CbGpPWpGaD
Nilvadipine—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000306	0.0032	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—NDUFA12—bone cancer	0.000305	0.0032	CbGpPWpGaD
Nilvadipine—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000303	0.00317	CbGpPWpGaD
Nilvadipine—CACNA1S—Alzheimers Disease—TP53—bone cancer	0.000292	0.00306	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—NDUFA12—bone cancer	0.000289	0.00303	CbGpPWpGaD
Nilvadipine—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000273	0.00286	CbGpPWpGaD
Nilvadipine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000262	0.00275	CbGpPWpGaD
Nilvadipine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000259	0.00271	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—NDUFA12—bone cancer	0.000254	0.00266	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—NT5C3A—bone cancer	0.000253	0.00265	CbGpPWpGaD
Nilvadipine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000249	0.00261	CbGpPWpGaD
Nilvadipine—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000248	0.0026	CbGpPWpGaD
Nilvadipine—CACNB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000248	0.00259	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—NT5C3A—bone cancer	0.000239	0.00251	CbGpPWpGaD
Nilvadipine—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000238	0.00249	CbGpPWpGaD
Nilvadipine—CACNA1D—Alzheimers Disease—TP53—bone cancer	0.000237	0.00248	CbGpPWpGaD
Nilvadipine—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000235	0.00246	CbGpPWpGaD
Nilvadipine—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000232	0.00243	CbGpPWpGaD
Nilvadipine—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000232	0.00243	CbGpPWpGaD
Nilvadipine—CACNA1S—Axon guidance—MET—bone cancer	0.000222	0.00232	CbGpPWpGaD
Nilvadipine—CYP2E1—tendon—bone cancer	0.00022	0.011	CbGeAlD
Nilvadipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000213	0.00223	CbGpPWpGaD
Nilvadipine—CYP2E1—spinal cord—bone cancer	0.000213	0.0106	CbGeAlD
Nilvadipine—CACNA1C—Metabolism—NT5C3A—bone cancer	0.00021	0.0022	CbGpPWpGaD
Nilvadipine—CACNA1C—Alzheimers Disease—TP53—bone cancer	0.000208	0.00218	CbGpPWpGaD
Nilvadipine—CACNB2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000207	0.00217	CbGpPWpGaD
Nilvadipine—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000203	0.00213	CbGpPWpGaD
Nilvadipine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000193	0.00203	CbGpPWpGaD
Nilvadipine—CACNB2—Axon guidance—MET—bone cancer	0.00019	0.00199	CbGpPWpGaD
Nilvadipine—CACNB2—Neuronal System—BRAF—bone cancer	0.00019	0.00199	CbGpPWpGaD
Nilvadipine—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000188	0.00197	CbGpPWpGaD
Nilvadipine—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000185	0.00194	CbGpPWpGaD
Nilvadipine—CACNA1S—Axon guidance—MMP2—bone cancer	0.000185	0.00194	CbGpPWpGaD
Nilvadipine—CACNA1D—Axon guidance—MET—bone cancer	0.00018	0.00189	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000175	0.00183	CbGpPWpGaD
Nilvadipine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000173	0.00181	CbGpPWpGaD
Nilvadipine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000165	0.00173	CbGpPWpGaD
Nilvadipine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000162	0.0017	CbGpPWpGaD
Nilvadipine—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000161	0.00168	CbGpPWpGaD
Nilvadipine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.00016	0.00168	CbGpPWpGaD
Nilvadipine—CACNB2—Neuronal System—MDM2—bone cancer	0.000159	0.00167	CbGpPWpGaD
Nilvadipine—CACNB2—Axon guidance—MMP2—bone cancer	0.000159	0.00166	CbGpPWpGaD
Nilvadipine—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000159	0.00166	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—MET—bone cancer	0.000158	0.00166	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—CDK4—bone cancer	0.000158	0.00166	CbGpPWpGaD
Nilvadipine—CACNA1C—Axon guidance—MET—bone cancer	0.000158	0.00166	CbGpPWpGaD
Nilvadipine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000157	0.00165	CbGpPWpGaD
Nilvadipine—CACNA1D—Axon guidance—MMP2—bone cancer	0.00015	0.00157	CbGpPWpGaD
Nilvadipine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000149	0.00156	CbGpPWpGaD
Nilvadipine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000145	0.00152	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000144	0.00151	CbGpPWpGaD
Nilvadipine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000143	0.0015	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000143	0.00149	CbGpPWpGaD
Nilvadipine—CACNA1S—Axon guidance—MMP9—bone cancer	0.000139	0.00146	CbGpPWpGaD
Nilvadipine—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000139	0.00146	CbGpPWpGaD
Nilvadipine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000137	0.00144	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—CDK4—bone cancer	0.000136	0.00142	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—MET—bone cancer	0.000136	0.00142	CbGpPWpGaD
Nilvadipine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000134	0.00141	CbGpPWpGaD
Nilvadipine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000132	0.00139	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—MMP2—bone cancer	0.000132	0.00138	CbGpPWpGaD
Nilvadipine—CACNA1C—Axon guidance—MMP2—bone cancer	0.000132	0.00138	CbGpPWpGaD
Nilvadipine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.00013	0.00137	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.00013	0.00136	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—MET—bone cancer	0.000129	0.00135	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—CDK4—bone cancer	0.000129	0.00135	CbGpPWpGaD
Nilvadipine—CYP2C19—Biological oxidations—GSTP1—bone cancer	0.000124	0.0013	CbGpPWpGaD
Nilvadipine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	0.000122	0.00128	CbGpPWpGaD
Nilvadipine—CACNB2—Axon guidance—MMP9—bone cancer	0.000119	0.00125	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—NT5C3A—bone cancer	0.000118	0.00124	CbGpPWpGaD
Nilvadipine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000115	0.00121	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—MMP2—bone cancer	0.000113	0.00119	CbGpPWpGaD
Nilvadipine—CYP2C9—Biological oxidations—GSTP1—bone cancer	0.000113	0.00118	CbGpPWpGaD
Nilvadipine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000113	0.00118	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—MET—bone cancer	0.000113	0.00118	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—CDK4—bone cancer	0.000113	0.00118	CbGpPWpGaD
Nilvadipine—CACNA1D—Axon guidance—MMP9—bone cancer	0.000113	0.00118	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—NDUFA12—bone cancer	0.000113	0.00118	CbGpPWpGaD
Nilvadipine—CACNA1S—Axon guidance—EGFR—bone cancer	0.000112	0.00118	CbGpPWpGaD
Nilvadipine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	0.000112	0.00117	CbGpPWpGaD
Nilvadipine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.000111	0.00117	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—ENO2—bone cancer	0.000111	0.00116	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—MMP2—bone cancer	0.000107	0.00112	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—ENO2—bone cancer	0.000105	0.0011	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—DHFR—bone cancer	0.000103	0.00108	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000102	0.00107	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000102	0.00107	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—MMP9—bone cancer	9.92e-05	0.00104	CbGpPWpGaD
Nilvadipine—CACNA1C—Axon guidance—MMP9—bone cancer	9.92e-05	0.00104	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—NDUFA12—bone cancer	9.74e-05	0.00102	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—DHFR—bone cancer	9.73e-05	0.00102	CbGpPWpGaD
Nilvadipine—CYP1A2—Biological oxidations—GSTP1—bone cancer	9.66e-05	0.00101	CbGpPWpGaD
Nilvadipine—CACNB2—Axon guidance—EGFR—bone cancer	9.64e-05	0.00101	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—GNA11—bone cancer	9.6e-05	0.00101	CbGpPWpGaD
Nilvadipine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	9.53e-05	0.000998	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—MMP2—bone cancer	9.42e-05	0.000987	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—NT5C3A—bone cancer	9.33e-05	0.000978	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—ENO2—bone cancer	9.22e-05	0.000966	CbGpPWpGaD
Nilvadipine—CACNA1D—Axon guidance—EGFR—bone cancer	9.12e-05	0.000956	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—GNA11—bone cancer	9.09e-05	0.000953	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—CYP3A4—bone cancer	8.71e-05	0.000912	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—NDUFA12—bone cancer	8.69e-05	0.000911	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—DHFR—bone cancer	8.55e-05	0.000896	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—MMP9—bone cancer	8.51e-05	0.000892	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—CYP3A4—bone cancer	8.25e-05	0.000864	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—NT5C3A—bone cancer	8.07e-05	0.000845	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—MMP9—bone cancer	8.06e-05	0.000844	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—EGFR—bone cancer	8.02e-05	0.00084	CbGpPWpGaD
Nilvadipine—CACNA1C—Axon guidance—EGFR—bone cancer	8.02e-05	0.00084	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—GNA11—bone cancer	7.99e-05	0.000837	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—NDUFA12—bone cancer	7.92e-05	0.00083	CbGpPWpGaD
Nilvadipine—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.46e-05	0.000781	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—GSTP1—bone cancer	7.45e-05	0.00078	CbGpPWpGaD
Nilvadipine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7.35e-05	0.000771	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—CYP3A4—bone cancer	7.24e-05	0.000759	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—NT5C3A—bone cancer	7.2e-05	0.000754	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—MMP9—bone cancer	7.08e-05	0.000742	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—GSTP1—bone cancer	7.05e-05	0.000739	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—EGFR—bone cancer	6.88e-05	0.00072	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—NDUFA12—bone cancer	6.77e-05	0.000709	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—NT5C3A—bone cancer	6.57e-05	0.000688	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—EGFR—bone cancer	6.51e-05	0.000682	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—GSTP1—bone cancer	6.2e-05	0.000649	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—EGFR—bone cancer	5.72e-05	0.000599	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—NT5C3A—bone cancer	5.61e-05	0.000588	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—NDUFA12—bone cancer	5.23e-05	0.000548	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—ENO2—bone cancer	5.17e-05	0.000542	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—DHFR—bone cancer	4.8e-05	0.000503	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—GNA11—bone cancer	4.49e-05	0.00047	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—NT5C3A—bone cancer	4.33e-05	0.000454	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—ENO2—bone cancer	4.09e-05	0.000428	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—CYP3A4—bone cancer	4.07e-05	0.000426	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—PTGS2—bone cancer	3.86e-05	0.000404	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—DHFR—bone cancer	3.79e-05	0.000397	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—PTGS2—bone cancer	3.65e-05	0.000383	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—GNA11—bone cancer	3.54e-05	0.000371	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—ENO2—bone cancer	3.53e-05	0.00037	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—GSTP1—bone cancer	3.48e-05	0.000364	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—DHFR—bone cancer	3.28e-05	0.000343	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—CYP3A4—bone cancer	3.21e-05	0.000337	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—PTGS2—bone cancer	3.21e-05	0.000336	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—ENO2—bone cancer	3.15e-05	0.00033	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—GNA11—bone cancer	3.06e-05	0.000321	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—DHFR—bone cancer	2.93e-05	0.000307	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—ENO2—bone cancer	2.88e-05	0.000301	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—CYP3A4—bone cancer	2.78e-05	0.000291	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.76e-05	0.00029	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—GSTP1—bone cancer	2.75e-05	0.000288	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—GNA11—bone cancer	2.73e-05	0.000287	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—DHFR—bone cancer	2.67e-05	0.00028	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—GNA11—bone cancer	2.49e-05	0.000261	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—CYP3A4—bone cancer	2.48e-05	0.00026	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.47e-05	0.000258	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—ENO2—bone cancer	2.46e-05	0.000258	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—GSTP1—bone cancer	2.38e-05	0.000249	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—DHFR—bone cancer	2.28e-05	0.000239	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—CYP3A4—bone cancer	2.26e-05	0.000237	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.25e-05	0.000236	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—GNA11—bone cancer	2.13e-05	0.000223	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—GSTP1—bone cancer	2.12e-05	0.000222	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—GSTP1—bone cancer	1.93e-05	0.000203	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.93e-05	0.000202	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.92e-05	0.000201	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—ENO2—bone cancer	1.9e-05	0.000199	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—PTGS2—bone cancer	1.8e-05	0.000189	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—DHFR—bone cancer	1.76e-05	0.000184	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—GSTP1—bone cancer	1.65e-05	0.000173	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—GNA11—bone cancer	1.64e-05	0.000172	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—PTGS2—bone cancer	1.42e-05	0.000149	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—GSTP1—bone cancer	1.28e-05	0.000134	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—PTGS2—bone cancer	1.23e-05	0.000129	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—PTGS2—bone cancer	1.1e-05	0.000115	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—PTGS2—bone cancer	1e-05	0.000105	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—PTGS2—bone cancer	8.56e-06	8.97e-05	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—PTGS2—bone cancer	6.61e-06	6.92e-05	CbGpPWpGaD
